Glomeria Therapeutics is an Italian biotech startup founded in 2010. Specializing in research and development, the company focuses on delivering hospital products, drugs, and medical therapy devices to patients with severe nephropathy and cardiopathy. With a strong emphasis on minimizing infrastructure costs and maximizing access to scientific knowledge, Glomeria conducts all creative and development phases in-house while outsourcing industrial development to specialized service firms. The company boasts a highly qualified management team and scientific board with extensive experience in pharmaceutical products and medical devices. Its last investment of €2.84M came from Sofimac Investment Managers and EASME - EU Executive Agency for SMEs on 01 October 2016.
General Information
BounceWatch is an independent company data service, not affiliated with Glomeria Therapeutics. To contact Glomeria Therapeutics, visit glomeria.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
Italy Market
Biotechnology
About Glomeria Therapeutics
Taxonomy: Biomedical Research, Nephrology, Cardiology, Pharmaceutical Development, Peritoneal Dialysis, Healthcare Innovation, Research and Development, Medical Therapy, Hospital Products, Medical Technology, Scientific Knowledge, Healthcare Industry, Innovation Management
Funding Rounds & Investors (3)
View AllGlomeria Therapeutics Alternatives & Competitors
View All AlternativesRenewing Renal Care
FAQ About Glomeria Therapeutics
Source: BounceWatch company record for Glomeria Therapeutics, https://bouncewatch.com/company/glomeria-therapeutics, updated 20 December 2024. When citing, please name BounceWatch and link this page.